Briacell Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.16

-0.16 (-3.71%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +495.7% upside

Low Target $18.09

Average Target $24.75

High Target $34.06

Current Price $4.16

Current
$4.16

Target
$24.75

$18.09 $24.75 avg $34.06

Scenario Analysis

Bear Case

$18.09

335.4%

Low target

Base Case

$24.75

+495.7%

Avg target

Bull Case

$34.06

+719.7%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$20.40

-79.6% from high

52-Week Low

$3.68

+12.9% from low

Target vs 52W High

$24.75

+21.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%